OmniAb Inc

NASDAQ:OABI

4.17

-0.17 (-3.92%)

7:17:00 PM EDT: $4.25 +0.08 (+1.92%)

Market Cap (Intraday)	460.03M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$25.72 Million
Adjusted EPS	$0.02

See more estimates

10-Day MA	$4.19
50-Day MA	$3.67
200-Day MA	N/A

See more pivots

OmniAb Inc Stock, NASDAQ:OABI

5980 Horton Street, Suite 600, Emeryville, California 94608

United States of America

Phone: +1.510.250.7800

Number of Employees:

http://www.omniab.com

Description

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. The firmâ�?��?�s platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.